Shattuck Labs, Inc. — Director's Dealing 2020

Oct 9, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Shattuck Labs, Inc. (STTK)
CIK: 0001680367
Period of Report: 2020-10-08

Reporting Person: Brous Tyler (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	30825	Direct
Common Stock	52745	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (629432)		Indirect
Series A Preferred Stock	$		Common Stock (16440)		Indirect
Series B Preferred Stock	$		Common Stock (27235)		Indirect
Series B-1 Preferred Stock	$		Common Stock (87132)		Indirect
Stock Option (Right to Buy)	$15.00	2030-09-24	Common Stock (27400)		Direct

Footnotes

F1: These shares are held directly by Lennox Dallas Partners, LP ("Lennox Partners"). The Reporting Person is the vice president of RS Holdings, Inc., the general partner of Lennox Partners. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except the extent of his pecuniary interest therein.

F2: Each share of Series A Preferred Stock is convertible into 6.85 shares of common stock at any time at the holder's election and will convert automatically immediately prior to the closing of the Issuer's initial public offering (the "IPO"). The Series A Preferred Stock has no expiration date.

F3: These shares are held directly by Lennox Dallas Holdings, LLC - Series 3. The Reporting Person is the Manager of Lennox Dallas Holdings, LLC - Series 3. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except the extent of his pecuniary interest therein.

F4: Each share of Series B Preferred Stock is convertible into 6.85 shares of common stock at any time at the holder's election and will convert automatically immediately prior to the closing of the IPO. The Series B Preferred Stock has no expiration date.

F5: These shares are held directly by Lennox Dallas Holdings, LLC - Series 9. The Reporting Person is the Manager of Lennox Dallas Holdings, LLC - Series 9. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except the extent of his pecuniary interest therein.

F6: Each share of Series B-1 Preferred Stock is convertible into 6.85 shares of common stock at any time at the holder's election and will convert automatically immediately prior to the closing of the IPO. The Series B-1 Preferred Stock has no expiration date.

F7: These shares are held directly by Lennox Dallas Holdings, LLC - Series 10. The Reporting Person is the Manager of Lennox Dallas Holdings, LLC - Series 10. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except the extent of his pecuniary interest therein.

F8: This option represents a right to purchase a total of 27,400 shares of the Issuer's common stock and will vest in in equal monthly installments from October 25, 2020 to September 25, 2021, subject to the Reporting Person's continued service to the Issuer.